Ind-Swift Ltd.

Company Description

Ind-Swift Ltd. pleased to introduce IndSwift Ltd, public listed company in Indian Stock market as one of the fastest growing pharmaceutical company of India. IndSwift is committed to build long lasting associations through the strategic selection of products, partners and markets. Today IndSwifts market reach spans over 70 countries across five continents as it serves discerning customers in Africa, Australia, Asia, Europe, Latin America & Central America, the middle east & CIS.
 
IndSwift Ltd. established in year 1984, IndSwift is one of the leading Indian manufacturer and exporter of APIs and Formulations. Kindly visit our website www.gbu.indswift.com. The turnover of IndSwift conglomerate expected to reach USD 475 million in financial year 20142015. IndSwift group is engaged in manufacturing, marketing and exports of APIs and Finished Formulations.
 
 Please note that our plant is approved by MHRA UK, TGA Australia, ANVISA Brazil, GCC Saudi Arabia, MOH Dubai and other African countries.

Company Information

  • Telephone:
  • Mobile Phone:
  • Business Type:Exporters
  • Year Established:1886
  • Number Of Employees:100+
  • Trade Capacity:Export Percentage:100 %
  • Main Products:Pharmacueitical Medicines, Finished Formaulation,
  • Address:Delhi, Delhi, India
  • Main Markets:Americas,Africa,Asia,Caribbean,Europe,Middle East,
  • Location:Chandigargh, India
  • Website:Visit website

Product

  • Pioglitazone 15/30/45
  • Pioglitazone 15/30/45
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries